GB9803992D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9803992D0
GB9803992D0 GBGB9803992.8A GB9803992A GB9803992D0 GB 9803992 D0 GB9803992 D0 GB 9803992D0 GB 9803992 A GB9803992 A GB 9803992A GB 9803992 D0 GB9803992 D0 GB 9803992D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9803992.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9803992.8A priority Critical patent/GB9803992D0/en
Publication of GB9803992D0 publication Critical patent/GB9803992D0/en
Priority to JP54784398A priority patent/JP4672820B2/en
Priority to ES98920635T priority patent/ES2179490T3/en
Priority to DE69807074T priority patent/DE69807074T2/en
Priority to PCT/GB1998/001307 priority patent/WO1998050385A1/en
Priority to EP98920635A priority patent/EP0986562B1/en
Priority to CA002288789A priority patent/CA2288789C/en
Priority to US09/180,623 priority patent/US6200975B1/en
Priority to AT98920635T priority patent/ATE221887T1/en
Priority to AU73428/98A priority patent/AU732455C/en
Priority to ZA9809317A priority patent/ZA989317B/en
Priority to CO98059605A priority patent/CO5011102A1/en
Priority to TW087117320A priority patent/TW487710B/en
Priority to PE00102598A priority patent/PE128999A1/en
Priority to HRP980584 priority patent/HRP980584A2/en
Priority to DZ980254A priority patent/DZ2644A1/en
Priority to CA002317416A priority patent/CA2317416A1/en
Priority to IL13711799A priority patent/IL137117A0/en
Priority to HU0100647A priority patent/HUP0100647A3/en
Priority to PL99341975A priority patent/PL341975A1/en
Priority to CN99803190A priority patent/CN1291194A/en
Priority to SK1277-2000A priority patent/SK12772000A3/en
Priority to JP2000533432A priority patent/JP2002504554A/en
Priority to YU46500A priority patent/YU46500A/en
Priority to NZ505695A priority patent/NZ505695A/en
Priority to TR2000/02469T priority patent/TR200002469T2/en
Priority to AU25368/99A priority patent/AU746719B2/en
Priority to EP99905069A priority patent/EP1070066A1/en
Priority to EA200000878A priority patent/EA002824B1/en
Priority to CZ20003114A priority patent/CZ291302B6/en
Priority to PCT/GB1999/000485 priority patent/WO1999043677A1/en
Priority to US09/600,988 priority patent/US6448249B1/en
Priority to BR9908155-5A priority patent/BR9908155A/en
Priority to KR1020007009325A priority patent/KR20010041234A/en
Priority to EEP200000514A priority patent/EE200000514A/en
Priority to US09/547,216 priority patent/US6310203B1/en
Priority to IS5575A priority patent/IS5575A/en
Priority to BG104705A priority patent/BG104705A/en
Priority to NO20004242A priority patent/NO20004242L/en
Priority to HR20000555A priority patent/HRP20000555A2/en
Ceased legal-status Critical Current

Links

GBGB9803992.8A 1997-05-08 1998-02-25 Therapeutic agents Ceased GB9803992D0 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GBGB9803992.8A GB9803992D0 (en) 1998-02-25 1998-02-25 Therapeutic agents
AU73428/98A AU732455C (en) 1997-05-08 1998-05-06 Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands
CA002288789A CA2288789C (en) 1997-05-08 1998-05-06 Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
AT98920635T ATE221887T1 (en) 1997-05-08 1998-05-06 SUBSTITUTED 1,2,4-TRIAZOLO(3,4,-A)PHTHALAZINE DERIVATIVES AS GABA-ALPHA 5 LIGANDS
DE69807074T DE69807074T2 (en) 1997-05-08 1998-05-06 SUBSTITUTED 1,2,4-TRIAZOLO [3,4, -A] PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
PCT/GB1998/001307 WO1998050385A1 (en) 1997-05-08 1998-05-06 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
EP98920635A EP0986562B1 (en) 1997-05-08 1998-05-06 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
JP54784398A JP4672820B2 (en) 1997-05-08 1998-05-06 Substituted 1,2,4-triazolo [3,4-a] phthalazine derivatives as GABAα5 ligands
US09/180,623 US6200975B1 (en) 1997-05-08 1998-05-06 Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands
ES98920635T ES2179490T3 (en) 1997-05-08 1998-05-06 DERIVATIVES OF 1,2,4-TRIAZOLO (3,4-A) FTALAZINA SUBSTITUTED AS LIGANDOS DE GABA ALFA 5.
ZA9809317A ZA989317B (en) 1998-02-25 1998-10-13 Substituted 1,2,4-triazolo[3,4-A]pyridazine.
CO98059605A CO5011102A1 (en) 1998-02-25 1998-10-14 1,2,4-TRIAZOL [3,4-A] SUBSTITUTED PIRIDAZINE
TW087117320A TW487710B (en) 1998-02-25 1998-10-20 Substituted 1,2,4-triazolo[3,4- a]pyridazine
PE00102598A PE128999A1 (en) 1998-02-25 1998-10-30 1,2,4-TRIAZOLO [3,4-A] SUBSTITUTED PIRIDAZINE
HRP980584 HRP980584A2 (en) 1998-02-25 1998-11-06 SUBSTITUTED 1,2,4-TRIAZOLO/3,4-a/ PHTHALAZINE
DZ980254A DZ2644A1 (en) 1998-02-25 1998-11-07 Triazolo-Ä3,4-aÜ-pyridazine substituted at 1,2,4.
EEP200000514A EE200000514A (en) 1998-02-25 1999-02-17 A substituted triazolopyridazine derivative, a pharmaceutical composition comprising it and its use in the manufacture of a medicament for enhancing cognition
HU0100647A HUP0100647A3 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3,4-a]pyridazine and its pharmaceutical use
CZ20003114A CZ291302B6 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3,4-a]phthalazine derivative
CA002317416A CA2317416A1 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3,4-a]pyridazine
PL99341975A PL341975A1 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazole[3,4-a]phtalazine
CN99803190A CN1291194A (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo [3,4-a] pyridazine
SK1277-2000A SK12772000A3 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3,4-a]pyridazine
JP2000533432A JP2002504554A (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo [3,4-a] pyridazine
YU46500A YU46500A (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo /3,4-a/pyridazine
NZ505695A NZ505695A (en) 1998-02-25 1999-02-17 3-(5-Methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl)methyloxy-1,2,4-triazolo[3,4-a]phthalazine and pharmaceuticals thereof and its use for the enhancement of cognition
TR2000/02469T TR200002469T2 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazole [3,4-a] pyridazine.
AU25368/99A AU746719B2 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo(3,4-a)pyridazine
EP99905069A EP1070066A1 (en) 1998-02-25 1999-02-17 SUBSTITUTED 1,2,4-TRIAZOLO 3,4-a]PYRIDAZINE
EA200000878A EA002824B1 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3-4-a]pyridazine
IL13711799A IL137117A0 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo [3,4-a] pyridazine
PCT/GB1999/000485 WO1999043677A1 (en) 1998-02-25 1999-02-17 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE
US09/600,988 US6448249B1 (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
BR9908155-5A BR9908155A (en) 1998-02-25 1999-02-17 Compound, pharmaceutical composition, use of the compound, and, process to intensify cognition in a subject suffering from decreased cognition
KR1020007009325A KR20010041234A (en) 1998-02-25 1999-02-17 Substituted 1,2,4-triazolo[3,4-a]pyridazine
US09/547,216 US6310203B1 (en) 1997-05-08 2000-04-11 Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands
IS5575A IS5575A (en) 1998-01-15 2000-07-25 Substitute 1,2,4-triazolo [3,4-a] pyridazine
BG104705A BG104705A (en) 1998-02-25 2000-08-22 Substituted 1,2,4-triazolo[3,4-a]pyridazine
NO20004242A NO20004242L (en) 1998-02-25 2000-08-24 Substitutes 1,2,4-triazolo [3,4-a] pyridazine
HR20000555A HRP20000555A2 (en) 1998-02-25 2000-08-25 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9803992.8A GB9803992D0 (en) 1998-02-25 1998-02-25 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9803992D0 true GB9803992D0 (en) 1998-04-22

Family

ID=10827588

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9803992.8A Ceased GB9803992D0 (en) 1997-05-08 1998-02-25 Therapeutic agents

Country Status (7)

Country Link
CO (1) CO5011102A1 (en)
DZ (1) DZ2644A1 (en)
GB (1) GB9803992D0 (en)
HR (1) HRP980584A2 (en)
PE (1) PE128999A1 (en)
TW (1) TW487710B (en)
ZA (1) ZA989317B (en)

Also Published As

Publication number Publication date
DZ2644A1 (en) 2003-03-15
TW487710B (en) 2002-05-21
CO5011102A1 (en) 2001-02-28
ZA989317B (en) 1999-08-25
PE128999A1 (en) 1999-12-16
HRP980584A2 (en) 1999-10-31

Similar Documents

Publication Publication Date Title
GB9820113D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9804885D0 (en) Therapeutic combination
GB9808663D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9815317D0 (en) Therapeutic agents
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9817838D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents
GB9816723D0 (en) Therapeutic agents
GB9811624D0 (en) Therapeutic use
GB9821179D0 (en) Therapeutic use
GB9812664D0 (en) Therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)